Biogen (BIIB) P/S (1999 - 2026)
Biogen (BIIB) P/S from Nov 1, 1999 to Jul 21, 2026. The TTM Biogen (BIIB) P/S is 3.01. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Biogen (BIIB)
| Year | P/S | Change |
|---|---|---|
| 2026 | 3.01 | +15.36% |
| 2025 | 2.61 | +13.28% |
| 2024 | 2.30 | -38.59% |
| 2023 | 3.75 | -2.83% |
| 2022 | 3.86 | +19.34% |
| 2021 | 3.23 | +13.15% |
| 2020 | 2.86 | -27.24% |
| 2019 | 3.93 | -15.02% |
| 2018 | 4.62 | -19.37% |
| 2017 | 5.73 | +5.36% |
| 2016 | 5.44 | -18.36% |
| 2015 | 6.66 | -19.50% |
| 2014 | 8.28 | -13.41% |
| 2013 | 9.56 | +52.38% |
| 2012 | 6.27 | +15.99% |
| 2011 | 5.41 | +58.64% |
| 2010 | 3.41 | -3.43% |
| 2009 | 3.53 | +317.93% |
| 2008 | 0.84 | +0.21% |
| 2007 | 0.84 | +15.71% |
| 2006 | 0.73 | +8.64% |
| 2005 | 0.67 | -32.02% |
| 2004 | 0.99 | +81.50% |
| 2003 | 0.54 | +10.64% |
| 2002 | 0.49 | -51.88% |
| 2001 | 1.02 | +9.09% |
| 2000 | 0.94 | +92.94% |
| 1999 | 0.49 | N/A |
Comparison Biogen (BIIB) P/S with competitors
Biogen (BIIB) P/S is 3.01.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -80.89% |
| NVO | Novo Nordisk | 0.66 | -78.00% |
| GRFS | Grifols SA | 0.67 | -77.70% |
| AMRN | Amarin Corp | 1.39 | -53.81% |
| SCLX | Scilex Holding Company | 1.92 | -36.37% |
| SNY | Sanofi | 2.18 | -27.46% |
| PFE | Pfizer Inc | 2.18 | -27.46% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -20.28% |
| GSK | GSK Plc | 3.22 | +7.13% |
| MRK | Merck & Co Inc | 4.54 | +50.73% |
| AZN | Astrazeneca plc | 4.58 | +52.36% |
| NVS | Novartis AG | 5.07 | +68.47% |
| AMGN | AMGEN Inc | 5.15 | +71.13% |
| GILD | Gilead Sciences Inc | 5.43 | +80.44% |
| JNJ | Johnson & Johnson | 6.34 | +110.68% |
| ABBV | Abbvie Inc | 7.15 | +137.59% |
| LLY | Lilly(Eli) & Company | 14.28 | +374.52% |